Loading...

We've got a brand new version of Simply Wall St! Try it out

Crescent Acquisition

Nasdaq:CRSA
Snowflake Description

Imperfect balance sheet with poor track record.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CRSA
Nasdaq
$309M
Market Cap
  1. Home
  2. US
  3. Diversified Financials
Company description

Crescent Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or business combination. The last earnings update was 6 days ago. More info.


Add to Portfolio Compare Print
CRSA Share Price and Events
7 Day Returns
0.2%
NasdaqCM:CRSA
1.1%
US Capital Markets
0.5%
US Market
1 Year Returns
-
NasdaqCM:CRSA
8.3%
US Capital Markets
12.8%
US Market
CRSA Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Crescent Acquisition (CRSA) 0.2% 0.7% 1.3% - - -
US Capital Markets 1.1% 6.4% 9.2% 8.3% 33.8% 58.5%
US Market 0.5% 4.3% 8% 12.8% 38.7% 44.5%
1 Year Return vs Industry and Market
  • No trading data on CRSA.
  • No trading data on CRSA.

Value

 Is Crescent Acquisition undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Crescent Acquisition to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Crescent Acquisition.

NasdaqCM:CRSA Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model Excess Returns Model
Stable EPS Median Return on Equity from the past 5 years.
= Stable Book Value * Return on Equity
= $0.16 * 3.3%
$0.01
Book Value of Equity per Share Median Book Value from the past 5 years. $0.16
Discount Rate (Cost of Equity) See below 7.7%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NasdaqCM:CRSA
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Capital Markets Unlevered Beta Simply Wall St/ S&P Global 0.75
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.753 (1 + (1- 21%) (0.02%))
0.835
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.83
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (0.835 * 5.96%)
7.71%

Discounted Cash Flow Calculation for NasdaqCM:CRSA using Excess Returns Model Model

The calculations below outline how an intrinsic value for Crescent Acquisition is arrived at using the Excess Return Model. This approach is used for finance firms where free cash flow is difficult to estimate.

In the Excess Return Model the value of a firm can be written as the sum of capital invested currently in the firm and the present value of excess returns that the firm expects to make in the future.

The model is sensitive to the Return on Equity of the company versus the Cost of Equity, how these are calculated is detailed below the main calculation.

Note the calculations below are per share.

See our documentation to learn about this calculation.

NasdaqCM:CRSA Value of Excess Returns
Calculation Result
Excess Returns = (Stable Return on equity – Cost of equity) (Book Value of Equity per share)
= (3.3% – 7.71%) * $0.16)
$-0.01
Terminal Value of Excess Returns = Excess Returns / (Cost of Equity - Expected Growth Rate)
= $-0.01 / (7.71% - 2.73%)
$-0.14
Value of Equity = Book Value per share + Terminal Value of Excess Returns
= $0.16 + $-0.14
$0.02
NasdaqCM:CRSA Discount to Share Price
Calculation Result
Value per share (USD) From above. $0.02
Current discount Discount to share price of $9.90
= -1 x ($9.90 - $0.02) / $0.02
-53105.6%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Crescent Acquisition is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Crescent Acquisition's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Crescent Acquisition's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqCM:CRSA PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in USD $0.09
NasdaqCM:CRSA Share Price ** NasdaqCM (2019-11-13) in USD $9.9
United States of America Capital Markets Industry PE Ratio Median Figure of 81 Publicly-Listed Capital Markets Companies 39.51x
United States of America Market PE Ratio Median Figure of 2,922 Publicly-Listed Companies 18.24x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Crescent Acquisition.

NasdaqCM:CRSA PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqCM:CRSA Share Price ÷ EPS (both in USD)

= 9.9 ÷ 0.09

109.06x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Crescent Acquisition is overvalued based on earnings compared to the US Capital Markets industry average.
  • Crescent Acquisition is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does Crescent Acquisition's expected growth come at a high price?
Raw Data
NasdaqCM:CRSA PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 109.06x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
-5.6%per year
United States of America Capital Markets Industry PEG Ratio Median Figure of 37 Publicly-Listed Capital Markets Companies 1.94x
United States of America Market PEG Ratio Median Figure of 2,023 Publicly-Listed Companies 1.46x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Crescent Acquisition, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Crescent Acquisition's assets?
Raw Data
NasdaqCM:CRSA PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in USD $0.16
NasdaqCM:CRSA Share Price * NasdaqCM (2019-11-13) in USD $9.9
United States of America Capital Markets Industry PB Ratio Median Figure of 153 Publicly-Listed Capital Markets Companies 6.6x
United States of America Market PB Ratio Median Figure of 5,070 Publicly-Listed Companies 1.73x
NasdaqCM:CRSA PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqCM:CRSA Share Price ÷ Book Value per Share (both in USD)

= 9.9 ÷ 0.16

61.88x

* Primary Listing of Crescent Acquisition.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Crescent Acquisition is overvalued based on assets compared to the US Capital Markets industry average.
X
Value checks
We assess Crescent Acquisition's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Capital Markets industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Capital Markets industry average (and greater than 0)? (1 check)
  5. Crescent Acquisition has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Crescent Acquisition expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Crescent Acquisition, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
-5.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Crescent Acquisition expected to grow at an attractive rate?
  • Crescent Acquisition's earnings are expected to decrease over the next 1-3 years, this is below the low risk savings rate of 2.7%.
Growth vs Market Checks
  • Crescent Acquisition's earnings are expected to decrease over the next 1-3 years, this is below the United States of America market average.
  • Unable to compare Crescent Acquisition's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
NasdaqCM:CRSA Future Growth Rates Data Sources
Data Point Source Value (per year)
NasdaqCM:CRSA Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts -5.6%
United States of America Capital Markets Industry Earnings Growth Rate Market Cap Weighted Average 5.1%
United States of America Capital Markets Industry Revenue Growth Rate Market Cap Weighted Average 3.7%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqCM:CRSA Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqCM:CRSA Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-09-30 0 2
2019-06-30 0 1
2019-03-31 0 0
2018-12-31 0 0
2017-12-31 -1 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Crescent Acquisition's earnings are expected to decrease over the next 1-3 years, this is not considered high growth.
  • Unable to determine if Crescent Acquisition is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqCM:CRSA Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Crescent Acquisition Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:CRSA Past Financials Data
Date (Data in USD Millions) EPS *
2019-09-30 0.09
2019-06-30 0.06
2019-03-31 0.01
2018-12-31 0.00
2017-12-31

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Crescent Acquisition will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Crescent Acquisition's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Crescent Acquisition has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Crescent Acquisition performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Crescent Acquisition's growth in the last year to its industry (Capital Markets).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Unable to establish if Crescent Acquisition's year on year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
  • Unable to compare Crescent Acquisition's 1-year earnings growth to the 5-year average as it has been trading publicly for less than 3 years.
  • Crescent Acquisition has become profitable in the last year making it difficult to compare the US Capital Markets industry average.
Earnings and Revenue History
Crescent Acquisition's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Crescent Acquisition Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:CRSA Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 2.27 0.37
2019-06-30 1.22 0.25
2019-03-31 0.17 0.09
2018-12-31 -0.01
2017-12-31 -0.01

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Crescent Acquisition made outstanding use of shareholders’ funds last year (Return on Equity greater than 40%).
  • It is difficult to establish if Crescent Acquisition has efficiently used its assets last year compared to the US Capital Markets industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Crescent Acquisition improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Crescent Acquisition's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Capital Markets industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Crescent Acquisition has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Crescent Acquisition's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Crescent Acquisition's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Crescent Acquisition is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Crescent Acquisition's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Crescent Acquisition's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 26x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Crescent Acquisition Company Filings, last reported 1 month ago.

NasdaqCM:CRSA Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 5.00 0.05 1.13
2019-06-30 5.00 0.09 1.14
2019-03-31 5.00 0.00 1.63
2018-12-31 0.02 0.26 0.04
2017-12-31 0.02 0.10 0.07
  • Crescent Acquisition's level of debt (1%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Crescent Acquisition's debt level has increased without past 5-year debt data.
  • Operating cash flow is negative therefore debt is not well covered.
  • Unable to confirm if the interest payments on Crescent Acquisition's debt are well covered by earnings due to lack of past financial data.
X
Financial health checks
We assess Crescent Acquisition's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Crescent Acquisition has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Crescent Acquisition's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Crescent Acquisition dividends.
If you bought $2,000 of Crescent Acquisition shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Crescent Acquisition's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Crescent Acquisition's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqCM:CRSA Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Capital Markets Industry Average Dividend Yield Market Cap Weighted Average of 42 Stocks 2%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1948 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Crescent Acquisition has not reported any payouts.
  • Unable to verify if Crescent Acquisition's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Crescent Acquisition's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Crescent Acquisition has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Crescent Acquisition's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Crescent Acquisition afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Crescent Acquisition has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Crescent Acquisition's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Todd Purdy
AGE 44
TENURE AS CEO 1 years
CEO Bio

Mr. Todd M. Purdy has been Chief Executive Officer of Crescent Funding Inc. since November 2018 and serves as its Director. Mr. Purdy is a seasoned private equity investor with years of investment industry experience. He was a Partner at Leonard Green & Partners, L.P until 2018. He joined Leonard Green & Partners in 2000 and focused on investments in the consumer, retail and services sectors. Prior to LGP, Mr. Purdy was an investment banker with Donaldson, Lufkin & Jenrette in Los Angeles and London. He was employed at DLJ since 1997. Mr. Purdy serves as a Member of the Board of Directors of, HITS, Inc.; Jo-Ann Stores, Inc.; Motorsport Aftermarket Group; The Sports Authority, Inc.; and Tourneau, Inc. Mr. Purdy is Director of Ralco Holdings, Inc. He was actively involved in LGP’s investments in Advantage Solutions and J.Crew. He served on the Board of Directors of Motorsport Aftermarket Group and Varsity Brands, Inc. He received a B.A. degree in Honors Business Administration from the Richard Ivey School of Business at the University of Western Ontario.

CEO Compensation
  • Insufficient data for Todd to compare compensation growth.
  • Insufficient data for Todd to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Crescent Acquisition management team in years:

1.5
Average Tenure
48.5
Average Age
  • The average tenure for the Crescent Acquisition management team is less than 2 years, this suggests a new team.
Management Team

Bob Beyer

TITLE
Executive Chairman
AGE
59
TENURE
1 yrs

Todd Purdy

TITLE
CEO & Director
AGE
44
TENURE
1 yrs

Chris Wright

TITLE
President
AGE
47
TENURE
2 yrs

Al Hassanein

TITLE
Chief Financial Officer
AGE
39
TENURE
0.1 yrs

Mike Wilhelms

TITLE
AGE
50
TENURE
2 yrs

George Hawley

TITLE
General Counsel & Secretary
AGE
51
TENURE
2 yrs
Board of Directors

Jean-Marc Chapus

TITLE
Chairman of the Board
AGE
59
TENURE
2 yrs

Bob Beyer

TITLE
Executive Chairman
AGE
59
TENURE
1 yrs

Todd Purdy

TITLE
CEO & Director
AGE
44
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Crescent Acquisition's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Crescent Acquisition has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Can We See Significant Institutional Ownership On The Crescent Acquisition Corp. (NASDAQ:CRSA) Share Register?

With a market capitalization of US$306m, Crescent Acquisition is a small cap stock, so it might not be well known by many institutional investors. … See our latest analysis for Crescent Acquisition NasdaqCM:CRSA Ownership Summary, August 1st 2019 What Does The Institutional Ownership Tell Us About Crescent Acquisition? … General Public Ownership The general public -- mostly retail investors -- own 80% of Crescent Acquisition.

Simply Wall St -

Company Info

Description

Crescent Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or business combination. The company was formerly known as Crescent Funding Inc. and changed its name to Crescent Acquisition Corp. in October 2018. The company was founded in 2017 and is based in Los Angeles, California.

Details
Name: Crescent Acquisition Corp.
CRSA
Exchange: NasdaqCM
Founded: 2017
$309,375,000
31,250,000
Website: http://www.crescentspac.com
Address: Crescent Acquisition Corp.
11100 Santa Monica Boulevard,
Suite 2000,
Los Angeles,
California, 90025,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqCM CRSA Class A Common Stock Nasdaq Capital Market US USD 17. Apr 2019
NasdaqCM CRSA.U Unit (1 Ordinary share Cls A and 1/2 Wrt) Nasdaq Capital Market US USD 08. Mar 2019
Number of employees
Current staff
Staff numbers
0
Crescent Acquisition employees.
Industry
Asset Management and Custody Banks
Diversified Financials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/11/14 00:58
End of day share price update: 2019/11/13 00:00
Last earnings filing: 2019/11/08
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.